Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00313352 · ClinicalTrials.gov registry record
Effects of Beta-adrenergic in Adults w/Transposition of Great Arteries on Systemic Ventricular Function
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 110
- Enrollment target
NCT00313352 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 110 participants.
The verdict
NCT00313352 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The purpose of this chart review study is to examine the effects of beta -adrenergic blocking agents on systemic ventricular dimensions, systemic atrioventricular valve function and exercise tolerance in patients with transposition of the great arteries (TGA) and systemic ventricular dysfunction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 1997-01 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00313352
The ClinicalTrials.gov registry entry for NCT00313352 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00313352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00313352 about?
NCT00313352 is a clinical study titled "Effects of Beta-adrenergic in Adults w/Transposition of Great Arteries on Systemic Ventricular Function". The purpose of this chart review study is to examine the effects of beta -adrenergic blocking agents on systemic ventricular dimensions, systemic atrioventricular valve function and exercise tolerance in patients with transposition of the great arteries (TGA) and systemic ventricular dysfunction.
What is the current status of trial NCT00313352?
This trial is currently completed. The enrollment target is 110 participants. The study started on 1997-01. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00313352?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.